Over the Counter (OTC) Drugs Market Size, Share, and Trends 2024 to 2034

The global over the counter (OTC) drugs market size accounted for USD 135.25 billion in 2025 and is forecasted to hit around USD 242.94 billion by 2034, representing a CAGR of 6.72% from 2025 to 2034. The North America market size was estimated at USD 39.77 billion in 2024 and is expanding at a CAGR of 6.94% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.

  • Last Updated : March 2025
  • Report Code : 1466
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID-19 Impact on Over the Counter (OTC) Drugs Market 

5.1. COVID-19 Landscape: Over the Counter (OTC) Drugs Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID-19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Over the Counter (OTC) Drugs Market, By Product

8.1. Over the Counter (OTC) Drugs Market, by Product Type

8.1.1. Analgesics

8.1.1.1. Market Revenue and Forecast

8.1.2. Cold & Cough Remedies

8.1.2.1. Market Revenue and Forecast

8.1.3. Digestives & Intestinal Remedies

8.1.3.1. Market Revenue and Forecast

8.1.4. Skin Treatment

8.1.4.1. Market Revenue and Forecast

8.1.5. Vitamins & Minerals

8.1.5.1. Market Revenue and Forecast

8.1.6. Others

8.1.6.1. Market Revenue and Forecast

Chapter 9. Global Over the Counter (OTC) Drugs Market, By Distribution Channel

9.1. Over the Counter (OTC) Drugs Market, by Distribution Channel

9.1.1. Drug Stores & Retail Pharmacies

9.1.1.1. Market Revenue and Forecast

9.1.2. Hospital Pharmacies

9.1.2.1. Market Revenue and Forecast

9.1.3. Online Pharmacies

9.1.3.1. Market Revenue and Forecast

Chapter 10. Global Over the Counter (OTC) Drugs Market, Regional Estimates and Trend Forecast

10.1. North America

10.1.1. Market Revenue and Forecast, by Product

10.1.2. Market Revenue and Forecast, by Distribution Channel

10.1.3. U.S.

10.1.3.1. Market Revenue and Forecast, by Product

10.1.3.2. Market Revenue and Forecast, by Distribution Channel

10.1.4. Rest of North America

10.1.4.1. Market Revenue and Forecast, by Product

10.1.4.2. Market Revenue and Forecast, by Distribution Channel

10.2. Europe

10.2.1. Market Revenue and Forecast, by Product

10.2.2. Market Revenue and Forecast, by Distribution Channel

10.2.3. UK

10.2.3.1. Market Revenue and Forecast, by Product

10.2.3.2. Market Revenue and Forecast, by Distribution Channel

10.2.4. Germany

10.2.4.1. Market Revenue and Forecast, by Product

10.2.4.2. Market Revenue and Forecast, by Distribution Channel

10.2.5. France

10.2.5.1. Market Revenue and Forecast, by Product

10.2.5.2. Market Revenue and Forecast, by Distribution Channel

10.2.6. Rest of Europe

10.2.6.1. Market Revenue and Forecast, by Product

10.2.6.2. Market Revenue and Forecast, by Distribution Channel

10.3. APAC

10.3.1. Market Revenue and Forecast, by Product

10.3.2. Market Revenue and Forecast, by Distribution Channel

10.3.3. India

10.3.3.1. Market Revenue and Forecast, by Product

10.3.3.2. Market Revenue and Forecast, by Distribution Channel

10.3.4. China

10.3.4.1. Market Revenue and Forecast, by Product

10.3.4.2. Market Revenue and Forecast, by Distribution Channel

10.3.5. Japan

10.3.5.1. Market Revenue and Forecast, by Product

10.3.5.2. Market Revenue and Forecast, by Distribution Channel

10.3.6. Rest of APAC

10.3.6.1. Market Revenue and Forecast, by Product

10.3.6.2. Market Revenue and Forecast, by Distribution Channel

10.4. MEA

10.4.1. Market Revenue and Forecast, by Product

10.4.2. Market Revenue and Forecast, by Distribution Channel

10.4.3. GCC

10.4.3.1. Market Revenue and Forecast, by Product

10.4.3.2. Market Revenue and Forecast, by Distribution Channel

10.4.4. North Africa

10.4.4.1. Market Revenue and Forecast, by Product

10.4.4.2. Market Revenue and Forecast, by Distribution Channel

10.4.5. South Africa

10.4.5.1. Market Revenue and Forecast, by Product

10.4.5.2. Market Revenue and Forecast, by Distribution Channel

10.4.6. Rest of MEA

10.4.6.1. Market Revenue and Forecast, by Product

10.4.6.2. Market Revenue and Forecast, by Distribution Channel

10.5. Latin America

10.5.1. Market Revenue and Forecast, by Product

10.5.2. Market Revenue and Forecast, by Distribution Channel

10.5.3. Brazil

10.5.3.1. Market Revenue and Forecast, by Product

10.5.3.2. Market Revenue and Forecast, by Distribution Channel

10.5.4. Rest of LATAM

10.5.4.1. Market Revenue and Forecast, by Product

10.5.4.2. Market Revenue and Forecast, by Distribution Channel

Chapter 11. Company Profiles

11.1. Bayer AG

11.1.1. Company Overview

11.1.2. Product Offerings

11.1.3. Financial Performance

11.1.4. Recent Initiatives

11.2. Takeda Pharmaceutical Company Ltd.

11.2.1. Company Overview

11.2.2. Product Offerings

11.2.3. Financial Performance

11.2.4. Recent Initiatives

11.3. Pfizer

11.3.1. Company Overview

11.3.2. Product Offerings

11.3.3. Financial Performance

11.3.4. Recent Initiatives

11.4. Johnson & Johnson Services Inc.

11.4.1. Company Overview

11.4.2. Product Offerings

11.4.3. Financial Performance

11.4.4. Recent Initiatives

11.5. Sanofi S.A.

11.5.1. Company Overview

11.5.2. Product Offerings

11.5.3. Financial Performance

11.5.4. Recent Initiatives

11.6. Reckitt Benckiser Group PLC

11.6.1. Company Overview

11.6.2. Product Offerings

11.6.3. Financial Performance

11.6.4. Recent Initiatives

11.7. Novartis AG

11.7.1. Company Overview

11.7.2. Product Offerings

11.7.3. Financial Performance

11.7.4. Recent Initiatives

11.8. Boehringer Ingelheim International GmbH

11.8.1. Company Overview

11.8.2. Product Offerings

11.8.3. Financial Performance

11.8.4. Recent Initiatives

11.9. GlaxoSmithKline PLC

11.9.1. Company Overview

11.9.2. Product Offerings

11.9.3. Financial Performance

11.9.4. Recent Initiatives

11.10. Mylan

11.10.1. Company Overview

11.10.2. Product Offerings

11.10.3. Financial Performance

11.10.4. Recent Initiatives

Chapter 12. Research Methodology

12.1. Primary Research

12.2. Secondary Research

12.3. Assumptions

Chapter 13. Appendix

13.1. About Us

13.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

According to Precedence Research, the global over the counter (OTC) drugs market size worth at USD 125.28 billion in 2024 and is predicted to reach over USD 229.01 billion by 2034.

The global over the counter (OTC) drugs market is expected to drive growth at a CAGR of 6.51% from 2025 to 2034.

The major players operating in the over the counter (OTC) drugs market are Bayer AG, Takeda Pharmaceutical Company Ltd., Pfizer, Johnson & Johnson Services Inc., Sanofi S.A., Reckitt Benckiser Group PLC, Novartis AG, Boehringer Ingelheim International GmbH, GlaxoSmithKline PLC, Mylan.

The growth in awareness of general health problems, as well as innovations in the healthcare and pharmaceutical industries, are driving the growth of over the counter (OTC) drugs market.

North America is the largest segment for over the counter (OTC) drugs market in terms of region.

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client